Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid)
Dermacyd PH_DETINLYN Tangerine Mix · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd PH\_DETINLYN Tangerine Mix (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) | DRUG | - |
Inclusion criteria: * Integral skin test in the region; * Use of cosmetic product of the same category; * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time; Exclusion criteria: * Lactation or gestational risk or gestation; * Use of Anti-i...
Dermacyd PH_DETINLYN Tangerine Mix is a small molecule product developed by Sanofi for hygiene use. It is also known as Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid). It has been studied in a Phase 3 safety trial conducted in Brazil.
Dermacyd PH_DETINLYN Tangerine Mix is used for hygiene. Its Phase 3 trial enrolled healthy female volunteers aged 10 years and older in Brazil. The specific indications for the product have not been disclosed.
Dermacyd PH_DETINLYN Tangerine Mix is developed by Sanofi, which trades under the ticker SNY. Sanofi is the sponsor of the clinical trial evaluating the product.
Dermacyd PH_DETINLYN Tangerine Mix is in Phase 3 development. Its single Phase 3 trial has been completed, and no trials are currently active. The product is investigational and is not approved.
Dermacyd PH_DETINLYN Tangerine Mix has been studied in one clinical trial, NCT00785642, titled Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety. The Phase 3 trial was completed and enrolled 30 healthy female volunteers aged 10 years and older in Brazil.
Yes, Dermacyd PH_DETINLYN Tangerine Mix is also known as Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid). The parenthetical name reflects lactic acid as the active ingredient. Both names refer to the same Sanofi product studied in the completed Phase 3 safety trial.